Saturday, July 4, 2026 Live from SEC EDGAR

The Wire Leaderboards Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

GMAB — GENMAB A/S SEC Filings | FilingIndex

GMABNasdaq

GENMAB A/S

Pharmaceutical Preparations · CIK 1434265

Develops and produces antibody-based therapeutics for cancer and other serious diseases

+ Watch View on EDGAR ↗

$17.51B

Market cap

$28.52

Last close

+3.2%

1D

+9.1%

5D

1.4M

Volume

Price$28.52+39.5%· 1Y

Jul 2L $20.30 · H $35.34Jul 2

480

Total filings

Jun 29, 2026

Last filing

—

Fiscal year end

All 6-K · 470 20-F · 7 SC 13G · 2 424B4 · 1 SC 13D · 1 SC 13D/A · 1

20-F20-FFeb 17, 2026 20-F20-FFeb 12, 2025 20-F20-FFeb 14, 2024 20-F20-FFeb 22, 2023 20-F20-FFeb 16, 2022 20-F

Similar companies

Comparable business profile · signals at a glance

NVONOVO NORDISK A S$223.2B+3.4%MOLNMOLECULAR PARTNERS AG$149.3M+1.3%AGMBAgomab Therapeutics NV$623.0M+6.6%GENBGenerate Biomedicines, Inc.$2.2B+5.5%ASNDAscendis Pharma A/S

20-F

Mar 29, 2021

20-F20-FMar 30, 2020

$18.0B

+2.5%

XNCRXencor Inc$1.1B-2.5%